On 9/4/2018, in Tien Giang, the Annual General Shareholder Meeting of Cai Lay Veterinary Pharmaceutical Joint Stock Company - CAILAYVETCO, a member of the Mavin Group, was held with the participation of shareholders represent 4,515,758 voting shares, accounting for 90% of the Company’s charter capital.
According to the report of the BOM, the business context of 2017 was very gloomy, especially the price of pork decreased from the beginning of the year, causing farmers to suffer heavy losses, which brought many difficulties for Cailayvetco. But Cailayvetco has seized the opportunity, overcome the challenges, and completed the business targets.
Here come the results of business operations in 2017:
- Total sales reached VND 141 billion, fulfilling 113.08% of the plan and surpassing 130% over the previous year.
- Operating profit increased by 34% on year, of which pre-tax profit grew 11% on year.
In 2018, as forecasted by experts, the livestock market may not fully recover. Still, the company remains confident of the industry's growth and sets its sights on continuing to grow, always being a trusted companion of its customers, continuing to affirm its position as one of the leading pharmaceutical company in Vietnam.